GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Quest Diagnostics Inc (FRA:QDI) » Definitions » Valuation Rank

Quest Diagnostics (FRA:QDI) Valuation Rank


View and export this data going back to 1996. Start your Free Trial

What is Quest Diagnostics Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Quest Diagnostics Valuation Rank Related Terms

Thank you for viewing the detailed overview of Quest Diagnostics's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Quest Diagnostics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Quest Diagnostics Inc (FRA:QDI) » Definitions » Valuation Rank
Comparable Companies
ICLR LH NTRA WAT ILMN RVTY MTD MEDP CRL EXAS TMO DHR XSWX:LONN A IQV IDXX SHSE:603259 XPAR:BIM QGEN XPAR:ERF
Traded in Other Exchanges
DGX:USA DGX:Mexico 0KSX:UK QDI:Germany Q1UE34:Brazil
Address
500 Plaza Drive, Secaucus, NJ, USA, 07094
Website
https://www.questdiagnostics.com
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the us. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.